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ABSTRACT The trithorax (trx) gene functions in segment
determination in Drosophika through interaction with genes of
the bithorax complex and Antenhapedia complex. Genetic
evidence suggests that trx may be considered a positive regu-
lator of homeotic genes. Sequencing ofcDNAs corresponding to
the entire trx transcription unit revealed the existence of an
unusually long open reading frame encoding 3759 amino acids.
The main features of the predicted trx protein are several
cysteine-rich regions which can be folded into zinc ringer-like
domains. Cysteine-rich portions expressed from trx cDNAs in
Escherichia coli are capable of zinc binding in vitro, suggesting
a possible function for the trx product as a metal-dependent
DNA-binding protein. Analysis of trx mutant embryos with
antibody to the Ultrabithorax (Ubx) gene product showed
decreased staining in parasegment 6 of the ventral nerve cord
of late embryos. However, expression of Ubx was not affected
in embryos carrying the lethql mutation trxE3, W which one of
the putative zinc finger-like domains of the trx protein is
deleted. This differential effect of theE3 mutation suggests that
trx exhibits other function(s) besides those involved in the
regulation of Ubx expression in the ventral nerve cord of the
embryo.
In the Drosophila embryo, homeotic genes including mem-
bers of the bithorax complex (BX-C) and Antennapedia
complex (ANT-C) directly control the unique pathways of
differentiation followed by particular segments (1, 2). One of
the central questions in understanding homeotic gene func-
tion concerns the mechanism by which segment-specific
expression patterns are achieved. Genes of the gap and
pair-rule classes are believed to define domains in which
homeotic genes are activated during embryogenesis (3-6),
and cross-regulatory interactions between BX-C and ANT-C
genes are important in pattern maintenance by preventing
ectopic expression of individual genes (7-9). In addition,
regulatory genes have been identified by mutations which
cause homeotic transformations in multiple segments. One
such regulatory gene is trithorax (trx), originally named
Regulator-of-bithorax (10); mutations in trx cause transfor-
mations of the first and third thoracic segments towards the
second thoracic segment and transformations in the abdomen
to a more anterior pattern (11). Since the trx effect is
suppressed by extra copies of the BX-C and enhanced by a
reduced copy number, it has been suggested that trx behaves
genetically as an activator of the BX-C (12). However,
appropriate expression of BX-C genes can be initiated in the
embryo in the absence of trx function, and therefore it
appears that trx is required mainly for the maintenance of
BX-C activity (13). In addition to its interactions with the
BX-C, trx also affects the function of the ANT-C (14, 15). A
requirement for trx activity has been demonstrated in the
Telo
.1 1
__ \svi~ lr .v-
Plrib,ry]7 P2 BIB B16 B17 Bli E3
5'
AU& 16 c1A2 6C12 UAUG UAA
Centro
-..L- DNA
-
1 kb
3'
RNA
FIG. 1. Structure of the trx locus. (Upper) Genomic DNA from
the trx locus with mapped mutations indicated: P[rib, ry]7, P2, B18,
B16, and B17 are insertions; BJJ and E3 are deletions. The BJJ
deletion leads to a frameshift and thus terminates the ORF, while E3
is an in-frame deletion (see Fig. 2). Telo, telomeric; Centro, centro-
meric. (Lower) Composite structure of trx mRNA, based on cDNAs
(15, 7A2, and 6C12) isolated previously (16) and sequenced in this
work. Gaps between the cDNA clones were bridged by synthesis of
DNA from poly(A)+ RNA with oligonucleotide primers, followed by
PCR amplification (refs. 21 and 22; stippled regions). The PCR
products and the corresponding genomic region were sequenced to
provide complete overlaps. The ORF is indicated by its AUG start
and UAA stop. Introns 2-4 and the boundaries of intron 1 were also
sequenced. Filled and open boxes above the RNA map indicate the
positions of cysteine-rich domains, which have possible zinc finger
structure, and runs of acidic amino acids, respectively (see text and
Figs. 2 and 3).
imaginal cells that give rise to different tissues of the adult
(14).
The trx gene has been cloned by isolating DNA from the
chromosomal region 88B, to which five insertional trx mu-
tations map (16). The gene comprises a transcription unit of
about 25 kilobases (kb) from which two major RNAs of
similar size are derived. These RNAs are distributed uni-
formly in the early embryo, consistent with the requirement
for trx function in many if not all segments (16). In the present
paper we extend the molecular and genetic analysis of the trx
gene. A set of overlapping cDNAs corresponding to the
major transcripts has been obtained and sequencedt reveal-
ing the existence of zinc finger-like structures in the predicted
trx protein. Fusion proteins derived from the open reading
frame (ORF) of the trx gene bind zinc in vitro, providing an
additional basis for the hypothesis that the trx product is a
metal-dependent nucleic acid-binding protein. We also pro-
vide evidence that trx functions as a positive regulator of
Ultrabithorax (Ubx) expression in the embryo and has addi-
tional functions required for survival.
Abbreviations: ANT-C, Antennapedia complex; BX-C, bithorax
complex; ORF, open reading frame; PCR, polymerase chain reac-
tion; PS, parasegment.
*Present address: Division of Biology 156-29, California Institute of
Technology, Pasadena, CA 91125.
tThe sequence reported in this paper has been deposited in the
GenBank data base (accession no. M31617).
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MATERIALS AND METHODS
cDNA Sequencing. Nucleotide sequence was determined
for both strands by the Sequenase protocol of United States
Biochemical, after subcloning of EcoRI fragments in Blue-
script plasmid, by the exonuclease III/mung bean or S1
nuclease procedure of Statagene. In cases ofambiguities both
strands were also sequenced with oligonucleotide primers.
To localize mutations, both wild-type and mutant genomic
DNAs were used as templates in the polymerase chain
reaction (PCR) to synthesize fragments which cover the
entire trx gene except the large intron. Fragments from
mutants covering the deletions were subcloned in Bluescript
plasmid and sequenced.
lacZ Fusion Constructs. Parts of the trx cDNA (see legend
to Fig. 4) were obtained by cleavage with restriction enzymes
or by PCR and cloned in frame at the 3' end of the lacZ gene
ofpUR 290, 291, or 292 vector (17). Western blotting and 65Zn
binding assay were performed as described (18).
Staining of Embryos with Antibody to the Ubx Protein.
Twelve- to 15-hr-old embryos were collected from each cross
and fixed as described (19). After blocking with 5% horse
serum in PBS/Triton (phosphate-buffered saline containing
0.15% Triton X-100) for 3 hr, embryos were incubated
overnight at room temperature with diluted culture superna-
tant (1:1) containing FP.3.38, a monoclonal antibody against
Ubx protein (20). Embryos were washed several times for 2
hr each with PBS/Triton and then incubated for 2 hr with
biotin-conjugated anti-mouse antibody (Vector Laboratories)
diluted 100-fold in PBS/Triton containing 5% horse serum.
Before and after a further 2-hr incubation with the avidin/
biotin-peroxidase complex (Vector Laboratories), embryos
were washed extensively with PBS/Triton. Diaminobenzi-
MGRSXFPGXPSXSI NRXRI SVLQLEDDAAtPAEPQQPAPESQQPSGSGSGSSAAREXGNNCDNDEDDHAPGGASI SGHTASSSAGSGNSGNGSSSGSSTG
SGSSGSGSTNGGSUNGGTHHXSAANLDXEAUTXDQNGDGDKTRGNUSSAPSGXLSAAASGXALSXSSRTFSASTSVTSSGRSSGSSPDGNSGASSDGASS
GISCGXSTAXSTEASSGXLAXTTGAGTCSSAXSSXASSLEQLVXQQPLVSGACLXALFUATPATSTGLACALVSPGGSSQGGTFPISAALLRARHNSNHH
FXXLNLARGEVMLPSTSXLXQLNSPUUDNPSPSPPILSGSTPSUEGGIGVGGUSPGEDAALXRVLTEMPNEVARDPSPSSCTAAANGAASGXGSASNGP
PAIIASSGDGSSPXSGADTGPSTSSTTAXQHXTVTFRNVLETSDDXSWXRFWIPDIRIPIVSIMXXDSLNRPLMYSRGGECIVRPSILSHILNIXSNIDX
LMSLXFRSAGASSSSSMQESRSSSNUFGLSRAFGAPMDEDDEGGVTFRRNDSPEDQNMAEDDEMDDDDDDEEAEEDDQNEDDNDEAASEXSAETEHSAGA
DERDPDEXQLVMDSHFULPXRSTRSSRII XPXRLLEEGAISTXXPLSLGDSXGXNUFGTSSSSAGSTASTFSASTHLHLGXETFFNFGTLXPNSSAAGI
FVLRQPRLQFQADIQQATFAAPXACPTSPSAIPXPANSLATSSFGSLASTNSSfPTPSACSICSAWJSSXEUTQARXYGVUACDUCRXFFSMtThXSI
SANSSTANTSSGSQQYLQCXGNEGSPCSIHSAHSQLXNFXXFYXDRCTACWLXXCMISFQLPAAHRSRLSAILPPGMRGEAAAREEHSAELLSPTGSLRF
TSTASSSSPSUWASTSVXUXSSGDSTSALTSI XPPLAENIUTFGSTPLLRPAILEIPLFLXISIAADQMLAAAEAISPSLTXXNSHQEHEHUHESEQSE
XLLSPTQAGTXXSGAAEAQVEEVQPQXEEAPQTSTTTQPSASNGASHGVPQAELAGETMATGDTLHRQRIDLPGPRVHHUCRSASIULGQPLATFGEDQQ
PEDAADMQQEIAAPVPSAIMEPSPEXPTHIVTDENDNCASCXTSPUGDESXPSXSSGSAQAEVXXATALGXEGTASAAGGSSAHVTTRNIAAASNLIUAA
SXHQRNGDIATSSSVTQSSNQTQGRXTXEHRQQRTLISIDFUEIYDPAEUCQTGFGLIVTETUAQRALCFLCGSTGLDPLIFCACCCEPYHQYCUQDEYV
LHHGSFEDTTLMGSLLETTUNASTGPSSSLNQLTQRLMULCPRCTVCYTCNMSSGSXVXCQXCQXIYHSTCLGTSHRLLGADRPLICUNCLHCXSCSTTX
VSHFVGNLPMCTGCFXLRXXGNFCPICQRCYDDNDFDLXMMECGDCGQWFHSXCEGLSDEQYLLSTLPESIEFICHHCARRNESSHIHAEELJRQAVMEE
FXASLYSVLXLLSHSRQACALLHLSPRHNURCTCGASSNQGXLQPXALQFSSGSDNGLGSDGESQNSDDVYEFXDQQQQQQQRNAtNMNPRUXPLPCSCQ
QHISHSQSFSLUDIQXIAGNSYVUSLEEFIWDMISQUIQQSNCDELDIAYXELLSEQFPUFQNETXACTDALEEDMFESCSGGVEDLQDAGGVSASVYNE
HSTSQAESRSGVLDIPLEEVDDFGSCGIXMRLDTRMCLFCRXSGEGLSGEEARLLYCGHDCUVHT1CAM1LSAEVFEEIDGSLQNUHSAVARGRMIHCTUC
GNRGATVGCWURSCGE-HVPCARSIDCAFLTDHSMYCPAHAHNGIALXANGSPSVTYESIFEVSRPVYUELDRXRHHLIEPARVQFHIGSLEVRQLGAI
VPRFSDSYEAWUPINFLCSRLYUSSXEPUHIVEYTURTTIQI1SSSTLTALDVGRt1YTUDHTNPNSXEVQLGMAQIARLJHTSLARSEFLENGGTDIJSGEFP
NPNSCUPPDQHTEEEPQQQADLLPPULTSPLXFLGLSTHGGLLLULLLGWURLXQGGELXDAIFEDLPHELLDGISILDIFLYDDRTDLFAISEQSXDG
TQAMTSNQAQ1Q1QQAGGANSUSICDEDTRNSNTSLGNGtJPASNPVEDAMLSAARIISSQVQMLXTLAUPXLDGNSAMATA IRRHLSHNLAEGVFLTLSS
QQRNIXEMATVAGVSRRQSISETSVEGVATTSGSVRSXSFTLJSAAXRYFEXSEGREEAAHMRIMQMDGVDDSITEFRIISGDGNLSTAQFSGQVHCDRCQ
CTYRMYDAFQRHLPSCSPTMSSMETESDVSGQGMTNMATQISAESLNELQXQLLANAGGLICLQSATSFPQVQSLGSLGQFGLQGLQQLQLQPQSLGDGF
FLSQPDPATQADTDDLQIYANSLQSLAAMLGGGFTLAQPTUTAPAQPQLI ASTIIPDGTQQFIQIPQTMQATTTPTATYQTLQATfiTDHHIMLPLTAAGX
PLXTVATXAAQQAAUXQRQLXSGHQVJPIQAXLQPHPQQHQQQQQTQVQQPITUMGQMLLQPQLLFQSSTQTQAPQIILPQAQPQNIISFVTGDGSQGQP
LOYISIPTAGEYXPQPQPTATPTFLTTAPGAGATYLQTDASGNLULTTTPSISGLQMLTAQSLQAQPWIGTLIQPQTIQLGGGADGNQPGSNQQPLILG
GTGGGSSGLEFATTSPQVILATQPMYYGLETIVQNTVMSSQQFVSTAMPGMLSQNASFSATTT(IFQASXIEPIVDLPAGYWLNMTGDASSAGTFLNAA
SVLQQQTQDDTTTQILQNANFQFQSVPTSSGASTSMDYTSPUMVTAXIPPVTQIXRTMAQAXAAGISGVGXVPPQPQWVNHVLPTSIVTQQSQLQVXNSN
LXQSQVXGHAASGTGTTCGAPPSIASHPLQHHTIMIRPIHHLEVHPXVMXPTPXVQNQIIHSLLQQQQQQQPQLQQQIPAVNMQPXVTISQQRIPAQTQ
QQQLQQAQMIHIPQQQQPLQQQQVQVOPSMPIITLAEAPVVQSQFVMEPQALEQQELANRUQHFSTSSSSSSSNCSLPTINNPMQQQAPSTTSSSTTRP
TNRULPMQQRQEPAPLSNECPUVSSPTPPXPVEQPIIHQTSASVSXCYAQXSTLPSPVYEAELXVSSVLESIUPDUTMDAILEEQPVTQSIYTEGLYEH
NSPGESKTEQLLLQQQQREQLNQQLUNNGYLLDXHTFQVEPMDTDUVYREEDLEEEEDEDDDFSLXMRTSACNDHEMSDSEEPAUHDHISKILDNLTNDDC
ADSIATATTMEUDASAGYQQILEDVLATTAAQSAPTEEFEGALETAAVEAAATYINEtiADAHULDLXQLQMGVELELRRRHEEQRTUSQEQEQSAAIVUP
TAAAPEPPQPIQEPXKKTGPHLLYEIQSEDGFTYXSSSITEIWEHUFEAJQVARRAHGLTPLPEGPLADMGGIQMIGLHTNALXYLIEQLPGUEXCSXYT
PHYHHRNGNUSTAANGAHGGNLGGSSASAALSVSGGDSHGLLDYGSDQDELEENAYDCARCEPYSMRSEYDMFSULASRHRHQPIQUFVQPSDNELUPRR
GTGSNLPMAMHYRTLXETYHDYVGVFRSHIHGRGLYCTXDIEAGEMVIEYAGELIRSTLTDXRERYYDSRGIGCYMFRIDDNLWDATMRGNAARFINHC
CEPNCYSXJVDILGHHHIIIFAURRIUQGEELTYDYHFPFEDEXIPCSCGSXRCRXYLN
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FIG. 2. Amino acid sequence of the predicted trx protein. The nucleic acid sequence of 12,445 nucleotides has been submitted to GenBankt;
the single long ORF predicts a protein of 3759 amino acids, which is shown in one-letter code. Two introns (at positions 362 and 754) are indicated
by triangles. Cysteine and some histidine residues found in putative finger-like structures are indicated by thick underlining, as are the aspartic
and glutamic residues in two highly acidic regions. The beginning of the deletion in trxBlI is indicated by a filled circle after residue 658; this
deletion of 833 nucleotides (2817-3649) leads to a frameshift and thus terminates the ORF. trx" is a deletion of 832 nucleotides (7336-8167)
together with an insertion of 19 nucleotides of unknown origin, and is therefore in frame; the deleted residues are underlined lightly.
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FIG. 3. Putative finger domains of the predicted trx protein. (Top) cDNA map indicating the positions of cysteine-rich regions (indicated by
bars above the map). (Middle) Overall pattern ofcysteine (C) and histidine (H) residues in the cysteine-rich regions. Possible zinc finger structures
are indicated by horizontal lines above the sequence, and numbered. The central region (domains 4-6) may be folded in different ways, yielding
up to 5 finger-like structures. Domain 9 is deleted by the trx"- mutation. AA, amino acids. (Bottom) Alignment of the proposed finger structures.
Domain numbers are given on the left; numbers on the right identify the last residue of each structure. Amino acids that are identical in domains
1 and 2 or 7 and 8 are boxed.
dine was used as the substrate for peroxidase as recom-
mended by the vendor (Amersham). Embryos with suitable
staining were mounted in Permount and examined under a
Zeiss Axioplan microscope equipped with Nomarski optics.
RESULTS
Sequence of the trx cDNA. Fig. 1 Upper shows a map of the
trx region, indicating the five insertion mutations mapped
previously (16) and two additional deletion mutations (see
also below). Three large cDNAs (15, 7A2, and 6C12; ref. 16)
were selected for sequence analysis. Overlaps between these
cDNA clones were generated by the PCR technique, and the
entire transcript is represented in Fig. 1 Lower. Comparison
ofcDNA sequences with genomicDNA showed the presence
of only four introns. The combined sequence revealed a
single ORF more than 11 kb long, predicting a protein of 3759
amino acids (Fig. 2). A main feature of the predicted trx
protein is its cysteine-rich regions, mostly in the central part
of the protein; these regions are indicated by the solid blocks
above the cDNA map in Fig. 1 and by heavy underlines in
Fig. 2 and will be discussed further below. In addition there
are two acidic domains consisting of runs of aspartic and
glutamic residues, which are heavily underlined in Fig. 2 and
indicated by open boxes in Fig. 1. Additional regions with a
net negative charge occur at amino acids 1700-2300 and
3100-3450.
The cysteine-rich regions of the trx protein can be arranged
into sequence motifs that have some similarity with the zinc
finger domain, as outlined in Fig. 3. The map at the top shows
the location of the cysteine-rich domains and is numbered for
reference to the lower parts of the figure. The middle section
illustrates the spacing of the cysteine motifs in the central part
of the protein, with putative finger domains overlined and
numbered; clustering of groups of domains is apparent. The
lower part of Fig. 3 gives an alignment of nine regions which
emphasizes their arrangement as putative zinc finger motifs.
The alignment in the central region (motifs 3-6) is somewhat
arbitrary since the multiple cysteine residues permit several
arrangements of putative finger structures. The main motif is
C2C(H) (C, cysteine; H, histidine; 2 indicates the number of
other amino acids), which occurs 27 times in the trx protein.
Additional similarities are restricted to adjoining structures (1
and 2; 7 and 8) which share some residues beyond the
cysteines and have similar loop lengths. The arrangement of
cysteines in the trx protein shows some similarity to the C,
type of nucleic acid-binding fingers found in hormone recep-
tors, the Drosophila transposon copia, and certain viral
proteins (23-26). This similarity, however, is largely re-
stricted to a general cysteine (and occasionally histidine)
motif; with respect to the presence of other conserved amino
acids, loop length, and the number offingers in the protein the
trx protein is quite distinct from previously reported exam-
ples.
Expression Studies: Cysteine-Rich Regions Bind Zinc in
Vitro. Portions of the trx cDNA were fused to a lacZ
expression vector and expressed in Escherichia coli. The
various fusions cover almost the entire ORF in overlapping
segments (Fig. 4A). All of these constructs led to the pro-
duction of proteins of the predicted molecular size (see Fig.
4B for examples), confirming the existence of a continuous
ORF extending through more than 11 kb ofDNA sequence.
The possibility that the cysteine-rich regions of the trx
product fold into zinc finger-like structures predicts at a
minimum that these regions should be capable of binding
zinc. That this is indeed the case is illustrated in Fig. 4C. In
2114 Genetics: Mazo et al.
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FIG. 4. Zinc binding by trx fusion proteins. (A) Fusion constructs containing the following parts of trx cDNA are indicated below the map:
SI [nucleotides (nt) 2657-3043; amino acids (aa) 605-733], S2 (nt 3118-3490; aa 759-883), S4 (nt 4594-5391; aa 1251-1516), S7 (nt 7319-8107;
aa 2159-2421), S9 (nt 11,470-12,115; aa 3542-3757), LI (nt 1670-4672; aa 276-1276), L2 (nt 3426-6058; aa 861-1738), L4 (nt 4672-6058; aa
1276-1738), L5 (nt 5629-7078; aa 1595-2078), L6 (nt 6421-8107; aa 1859-2421), L7 (nt 8036-9703; aa 2398-2953), L8 (nt 8954-10,668; aa
2704-3275), and L9 (nt 9990-12,115; aa 3049-3757). Indication of cysteine-rich regions and acidic domains is as in Figs. 1 and 3. The ORF starts
at nt 842 and ends at nt 12,121. (B) Amido black staining of bacterial extracts expressing different fusion proteins (arrowheads). E6, partially
purified fusion protein including sequence encoded by the human papillomavirus E6 gene (18); GIG, -galactosidase. (C) Autoradiogram of a blot
of the gel shown in B after renaturation and labeling with 65ZnCI2.
general, the fusion proteins derived from different portions of
the trx ORF bind zinc in proportion to the number of
finger-like motifs they contain. Protein S4, representing the
multiple cysteine-motif region, binds zinc most intensely.
Protein S7, which contains one putative finger motif and is of
special interest since it is deleted by the mutation trxE3 (Fig.
1, see also below), shows only weak zinc binding which is of
uncertain significance. As an example of a known zinc-
binding protein, Fig. 4 B and C includes a protein derived by
fusion ofthe ORF ofthe human papillomavirus E6 gene to the
bacterial trpE gene (18).
Expression of Ubx in the Ventral Nerve Cord Is Affected by
Mutations in trx. trx is known to interact with genes of the
BX-C and may be a positive regulator of Ubx function (12).
To study the nature of this interaction in early development
we stained trx mutant embryos with antibody to the Ubx
product. In the nervous system of wild-type embryos the
expression domain of Ubx extends from parasegment 5 (PS5)
to PS12; within this domain PS6 is stained most strongly (refs.
27 and 28 and Fig. 5a). In contrast, Ubx expression in PS6 is
substantially reduced in trx mutant embryos (Fig. 5b). In
addition, a subset of cells in all parasegments that normally
expresses Ubx appears to be negative in mutant embryos,
consistent with an activator function of trx (12).
We wished to determine whether the effect on Ubx expres-
sion requires the entire trx product. For this purpose we
studied Ubx staining in embryos mutant for several trx alleles
(see legend to Fig. 5). Particularly interesting in this context
are two lethal trx alleles, trxB11 and trx3, both resulting from
short deletions (Fig. 1). The deletion in trxBII leads to a
frameshift which terminates the trx protein after the first 658
residues; trxB11 affects Ubx expression in the same way as a
total deletion ofthe trx locus [i.e., Df(3)red]. In contrast, trxE
deletes 271 amino acids in frame within the coding region
(Figs. 1 and 2). While trx' is a lethal allele, it does not affect
Ubx staining in the embryonic nervous system; thus, the
deleted segment of the protein is dispensable for regulating
Ubx expression up to this stage. Since trx' is a lethal
mutation and was originally isolated as a suppressor of
Polycomb (Pc) (30), it is clear that trx must have additional
functions beyond those involved in Ubx expression in the
embryonic nervous system.
DISCUSSION
The trx gene is required in multiple segments and tissues of
the fly and at different stages of development (14). The
product of trx interacts with genes of both the BX-C and the
ANT-C and behaves as an activator of the BX-C (12, 14, 15).
Two structural features of the predicted trx protein suggest
that this effect may be mediated by the function of the trx
product as a transcription factor. First, the trx protein
contains several cysteine-rich domains that resemble, in a
distant way, zinc finger structures of the Cx (hormone recep-
tor) type (Fig. 3). The protein segments containing these
domains are capable of binding zinc in vitro (Fig. 4), consis-
tent with such an interpretation. If, in fact, the trx product
proves to be a metal-dependent nucleic acid-binding .protein,
then it is clear that it represents a new type with only general
similarity to known classes of such proteins. Second, two
runs of acidic residues in the predicted trx protein resemble
acidic stretches in the protein products of the myc family and
the Drosophila engrailed gene (31). These motifs may be
functionally similar to activating domains of certain tran-
scription factors (32, 33).
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FIG. 5. Staining of the embryonic nervous system with antibody
to Ubx protein in wild-type (a) and trx mutant (b) embryos. Para-
segments are numbered in the photographs. Wild-type embryos show
much stronger staining in PS6 than in the other parasegments; in the
mutant, staining is almost uniform throughout the major Ubx-
positive domain. The embryo shown in this figure was homozygous
for trx3 (29); the same staining pattern was seen with homozygotes
for the large deletion Dft3)redP93 and for mutations trxE2, trxBA", and
trx18 (30). In contrast, the lethal mutation trxA3 (30) showed a
wild-type staining pattern (see also text).
We observed a distinct effect of trx mutations on the
expression of Ubx in the ventral nerve cord, leading to a
substantial decrease in PS6 and lesser reductions in some
cells in other parasegments. This finding is consistent with a
role for trx as a specific regulator of Ubx, at least at this stage
of development. The role of trx could be mediated through
one or several regulatory elements of the very long control
regions of Ubx (34). A comparison between the effect of trx
mutations and certain mutations in the Ubx control regions
reveals only limited similarities and suggests the possibility of
multiple actions of trx on the BX-C. A decrease of Ubx
expression in PS6 and more posterior parasegments, and an
increase in PS5, is associated with mutations in the bxd/pbx
region located upstream of the Ubx promoter (27, 28), while
a decrease of expression in PS5 is caused by the mutation
abi, which maps in the 3' region ofthe Ubx transcription unit
(28). The pattern of Ubx expression in trx mutants has
features reminiscent of both bxd/pbx and abx mutants.
Further, trx mutants show abdominal transformations (11),
implying that this locus also interacts with the regulatory
regions of abd-A or Abd-B, the other two genes in the BX-C.
trx may be considered a member of a class of regulatory
genes that are characterized by their interactions. Two un-
linked loci, ash-i and ash-2, are related to trx as shown by
their similar phenotypes, reciprocal enhancement, and sen-
sitivity to the allelic state of the maternal-effect genefsh (35,
36). Further, trx shares with these and a series of additional
loci the property of acting as suppressors ofPc (30). Pc is the
prototype of a class of genes with properties of repressors of
BX-C activity (37, 38). While both the Pc and trx groups
undoubtedly include genes with different molecular charac-
teristics and biological functions, the existence of regulatory
networks within and between these classes appears likely. Pc
was shown to encode a nuclear protein which is localized at
specific chromosomal sites in the Drosophila salivary gland
chromosomes, including those of the BX-C and ANT-C,
implying a plausible model for its apparent repressor activity
(39). The sequence of the predicted trx protein, as reported
here, suggests that trx as well may have a nuclear site of
action and may be an important member of such a regulatory
network.
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